Discover 1 curated intelligence briefings related to this specific topic.
As cancer rates climb among adults under 50, Multi-Cancer Early Detection tests are pivoting from experimental curiosity to clinical contenders. But can a methylation signal truly replace the gold standard of invasive screening?